Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-26-025973
Filing Date
2026-03-11
Accepted
2026-03-11 08:54:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 12344
2 LETTER TO THE BOARD OF DIRECTORS OF ISSUER ea028037502ex-a.htm EX-99.A 31742
3 TRANSACTIONS COMPLETED BY REPORTING PERSONS IN THE COMMON STOCK ea028037502ex-b.htm EX-99.B 10142
4 GRAPHIC ea028037502_ex-aimg1.jpg GRAPHIC 3083
  Complete submission text file 0001213900-26-025973.txt   60191
Mailing Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720
Business Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720 (978) 631-0152
Bluejay Diagnostics, Inc. (Subject) CIK: 0001704287 (see all company filings)

EIN.: 473552922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-93056 | Film No.: 26741682
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 650 GEORGIA ST #3200 VANCOUVER A1 V6B4P7
Business Address
Braeden Lichti (Filed by) CIK: 0001982476 (see all company filings)

Type: SCHEDULE 13D